SHE Intrinsic Valuation and Fundamental Analysis - Shedir Pharma Srl Unipersonale - Alpha Spread

Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 3.8 EUR
Market Cap: 43.4m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Intrinsic Value

The intrinsic value of one SHE stock under the Base Case scenario is 7.73 EUR. Compared to the current market price of 3.8 EUR, Shedir Pharma Srl Unipersonale is Undervalued by 51%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

SHE Intrinsic Value
7.73 EUR
Undervaluation 51%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Shedir Pharma Srl Unipersonale

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for SHE cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about SHE?
Bearish
Neutral
Bullish

Fundamental Analysis

Summary

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Shedir Pharma Srl Unipersonale

Provide an overview of the primary business activities
of Shedir Pharma Srl Unipersonale.

What unique competitive advantages
does Shedir Pharma Srl Unipersonale hold over its rivals?

What risks and challenges
does Shedir Pharma Srl Unipersonale face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Shedir Pharma Srl Unipersonale.

Provide P/S
for Shedir Pharma Srl Unipersonale.

Provide P/E
for Shedir Pharma Srl Unipersonale.

Provide P/OCF
for Shedir Pharma Srl Unipersonale.

Provide P/FCFE
for Shedir Pharma Srl Unipersonale.

Provide P/B
for Shedir Pharma Srl Unipersonale.

Provide EV/S
for Shedir Pharma Srl Unipersonale.

Provide EV/GP
for Shedir Pharma Srl Unipersonale.

Provide EV/EBITDA
for Shedir Pharma Srl Unipersonale.

Provide EV/EBIT
for Shedir Pharma Srl Unipersonale.

Provide EV/OCF
for Shedir Pharma Srl Unipersonale.

Provide EV/FCFF
for Shedir Pharma Srl Unipersonale.

Provide EV/IC
for Shedir Pharma Srl Unipersonale.

Show me price targets
for Shedir Pharma Srl Unipersonale made by professional analysts.

What are the Revenue projections
for Shedir Pharma Srl Unipersonale?

How accurate were the past Revenue estimates
for Shedir Pharma Srl Unipersonale?

What are the Net Income projections
for Shedir Pharma Srl Unipersonale?

How accurate were the past Net Income estimates
for Shedir Pharma Srl Unipersonale?

What are the EPS projections
for Shedir Pharma Srl Unipersonale?

How accurate were the past EPS estimates
for Shedir Pharma Srl Unipersonale?

What are the EBIT projections
for Shedir Pharma Srl Unipersonale?

How accurate were the past EBIT estimates
for Shedir Pharma Srl Unipersonale?

Compare the revenue forecasts
for Shedir Pharma Srl Unipersonale with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Shedir Pharma Srl Unipersonale and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Shedir Pharma Srl Unipersonale against its competitors.

Analyze the profit margins
(gross, operating, and net) of Shedir Pharma Srl Unipersonale compared to its peers.

Compare the P/E ratios
of Shedir Pharma Srl Unipersonale against its peers.

Discuss the investment returns and shareholder value creation
comparing Shedir Pharma Srl Unipersonale with its peers.

Analyze the financial leverage
of Shedir Pharma Srl Unipersonale compared to its main competitors.

Show all profitability ratios
for Shedir Pharma Srl Unipersonale.

Provide ROE
for Shedir Pharma Srl Unipersonale.

Provide ROA
for Shedir Pharma Srl Unipersonale.

Provide ROIC
for Shedir Pharma Srl Unipersonale.

Provide ROCE
for Shedir Pharma Srl Unipersonale.

Provide Gross Margin
for Shedir Pharma Srl Unipersonale.

Provide Operating Margin
for Shedir Pharma Srl Unipersonale.

Provide Net Margin
for Shedir Pharma Srl Unipersonale.

Provide FCF Margin
for Shedir Pharma Srl Unipersonale.

Show all solvency ratios
for Shedir Pharma Srl Unipersonale.

Provide D/E Ratio
for Shedir Pharma Srl Unipersonale.

Provide D/A Ratio
for Shedir Pharma Srl Unipersonale.

Provide Interest Coverage Ratio
for Shedir Pharma Srl Unipersonale.

Provide Altman Z-Score Ratio
for Shedir Pharma Srl Unipersonale.

Provide Quick Ratio
for Shedir Pharma Srl Unipersonale.

Provide Current Ratio
for Shedir Pharma Srl Unipersonale.

Provide Cash Ratio
for Shedir Pharma Srl Unipersonale.

What is the historical Revenue growth
over the last 5 years for Shedir Pharma Srl Unipersonale?

What is the historical Net Income growth
over the last 5 years for Shedir Pharma Srl Unipersonale?

What is the current Free Cash Flow
of Shedir Pharma Srl Unipersonale?

Discuss the annual earnings per share (EPS)
trend over the past five years for Shedir Pharma Srl Unipersonale.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Shedir Pharma Srl Unipersonale

Current Assets 41.9m
Cash & Short-Term Investments 1.2m
Receivables 17.6m
Other Current Assets 23.1m
Non-Current Assets 14.2m
Long-Term Investments 16k
PP&E 7.8m
Intangibles 5.5m
Other Non-Current Assets 824k
Current Liabilities 14.4m
Accounts Payable 9.1m
Accrued Liabilities 656k
Other Current Liabilities 4.7m
Non-Current Liabilities 5.7m
Long-Term Debt 4.6m
Other Non-Current Liabilities 1.1m
Efficiency

Earnings Waterfall
Shedir Pharma Srl Unipersonale

Revenue
59.4m EUR
Cost of Revenue
-23.6m EUR
Gross Profit
35.8m EUR
Operating Expenses
-27.3m EUR
Operating Income
8.5m EUR
Other Expenses
-2.8m EUR
Net Income
5.7m EUR

Free Cash Flow Analysis
Shedir Pharma Srl Unipersonale

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

SHE Profitability Score
Profitability Due Diligence

Shedir Pharma Srl Unipersonale's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Negative Free Cash Flow
Positive 3-Year Average ROIC
Positive 3-Year Average ROE
61/100
Profitability
Score

Shedir Pharma Srl Unipersonale's profitability score is 61/100. The higher the profitability score, the more profitable the company is.

SHE Solvency Score
Solvency Due Diligence

Shedir Pharma Srl Unipersonale's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Short-Term Solvency
80/100
Solvency
Score

Shedir Pharma Srl Unipersonale's solvency score is 80/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

SHE Price Targets Summary
Shedir Pharma Srl Unipersonale

Wall Street analysts forecast SHE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SHE is 8.27 EUR with a low forecast of 8.19 EUR and a high forecast of 8.52 EUR.

Lowest
Price Target
8.19 EUR
116% Upside
Average
Price Target
8.27 EUR
118% Upside
Highest
Price Target
8.52 EUR
124% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for SHE?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Previous Payment
-
Today
Next Payment
-
Today
Oct 7, 2024
Previous Payment
-
Next Payment
-
Ex-Dividend Date
-
Want to learn more about SHE dividends?

Click here to dive deeper.

Shareholder Yield

Current shareholder yield for SHE is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale

Country

Italy

Industry

Pharmaceuticals

Market Cap

43.2m EUR

Dividend Yield

0%

Description

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

Contact

SALERNO
Mercato San Severino
Via San Felice, 41,43
+39089894754
www.shedirpharma.com

IPO

2019-07-23

Employees

71

Officers

See Also

Discover More
What is the Intrinsic Value of one SHE stock?

The intrinsic value of one SHE stock under the Base Case scenario is 7.73 EUR.

Is SHE stock undervalued or overvalued?

Compared to the current market price of 3.8 EUR, Shedir Pharma Srl Unipersonale is Undervalued by 51%.

Back to Top